Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.dld.2021.03.013 http://scihub22266oqcxt.onion/10.1016/j.dld.2021.03.013 33941488!8086184!33941488     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Dig+Liver+Dis 2021 ; 53 (6): 677-681 Nephropedia Template TP {{tp|p=33941488|t=2021. Italian association for the study of the liver position statement on SARS-CoV2 vaccination |pdf=|usr=}}{{33941488}} gab.com Text Italian association for the study of the liver position statement on SARS-CoV2 vaccination JO: Dig Liver Dis http://www.kidney.de/pget.php?&tw=1&pmid=33941488 #FOAvip The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients. Twit Text FOAVip Italian association for the study of the liver position statement on SARS-CoV2 vaccination ????Dig Liver Dis http://www.kidney.de/pget.php?&tw=1&pmid=33941488 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33941488 #FOAvip English Wikipedia <ref>{{Cite pmid|33941488}}</ref> Italian association for the study of the liver position statement on SARS-CoV2 vaccination #MMPMID33941488 Russo FP; Piano S; Bruno R; Burra P; Puoti M; Masarone M; Montagnese S; Ponziani FR; Petta S; Aghemo A Dig Liver Dis 2021[Jun]; 53 (6): 677-681 PMID33941488show ga The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients. |*COVID-19 Vaccines/classification/pharmacology[MESH] |*COVID-19/epidemiology/prevention & control[MESH] |*Immunization Programs/methods/organization & administration[MESH] |*Liver Diseases/immunology/therapy[MESH] |Humans[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |Italy/epidemiology[MESH] |Liver Transplantation[MESH] |Patient Safety[MESH] |Patient Selection[MESH] |Risk Adjustment/*methods[MESH] |Risk Assessment[MESH] |SARS-CoV-2/immunology[MESH] |Transplant Recipients[MESH]Italian association for the study of the liver position statement on S(epmc).pdf DeepDyve Pubget Overpricing